Under construction – not a live service
Sign in

2023-507497-40-00CompletedPhase 1

A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participants With Untreated BCL-2 Immunohistochemistry (IHC)-Positive Diffuse Large B-Cell Lymphoma (DLBCL)

Source: EU CTIS (euclinicaltrials.eu) · Last updated 16 May 2024

Next steps

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
36 (actual)
First submitted
15 Jan 2024
Start date
31 May 2021
Lead sponsor
F. Hoffmann-La Roche AG
EU CT number
2023-507497-40-00
EudraCT number
2020-002376-12

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 36
  • 14 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Sites (14)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Hospital de la Santa Creu i Sant PauBarcelonaSpainCompleted
Hospital Universitari Vall d'HebronBarcelonaSpainCompleted
Hospital General Universitario Gregorio MarañónMadridSpainCompleted
Clínica Universidad de navarraPamplonaSpainCompleted
Centre Hospitalier Universitaire de LilleLilleFranceCompleted
Centre Hospitalier Universitaire De MontpellierMontpellier Cedex 5FranceCompleted
Centre Hospitalier Universitaire de NantesNantesFranceCompleted
Hopital Saint LouisParisFranceCompleted
Centre Hospitalier Lyon-SudPierre-BéniteFranceCompleted
Centre Hospitalier Universitaire de RennesRennesFranceCompleted
Centre Henri BecquerelRouen CedexFranceCompleted
IRCCS Istituto Nazionale Tumori Fondazione PascaleNaplesItalyCompleted
Azienda Ospedaliero Universitaria PisanaPisaItalyCompleted
Azienda Unità Sanitaria Locale della RomagnaRavennaItalyCompleted

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.